Target intelligence / Profile preview

DNA and other cellular components (DNA)

Target
DNA
Molecular classification
Nucleic acid, Macromolecule, Other
01

Overview

DNA and other cellular components represent a broad category of biological targets that are not specific proteins, but rather the fundamental building blocks of the cell, most notably deoxyribonucleic acid (DNA). DNA serves as the primary repository of genetic information, and its integrity is essential for cellular function, replication, and survival (Source: NIH). Many traditional chemotherapeutic agents, such as alkylating agents and platinum-based compounds, target DNA by forming covalent bonds or intercalating between base pairs, which inhibits replication and triggers programmed cell death (Source: StatPearls). While highly effective against rapidly proliferating cancer cells, these interactions are generally non-specific and can damage the DNA of healthy tissues, leading to significant toxicities (Source: PubMed). Beyond DNA, this category may include other macromolecules like RNA or structural lipids that are affected by certain non-specific cytotoxic or antiseptic agents. Consequently, while these targets are clinically validated, the lack of specificity remains a major challenge in modern drug design (Source: NIH).

Other names
Deoxyribonucleic acidGenomic DNACellular macromoleculesNon-specific cellular targets
02

Mechanism of action

Drugs targeting DNA typically act through covalent modification (alkylation), cross-linking of strands, or non-covalent intercalation between base pairs, all of which physically obstruct the machinery required for DNA replication and transcription (Source: StatPearls). These actions lead to the formation of DNA adducts and double-strand breaks, which activate DNA damage response pathways and, if the damage is irreparable, trigger apoptosis (Source: PubMed). Some agents also generate reactive oxygen species that cause oxidative damage to DNA and other cellular components like lipids and proteins (Source: NIH).

03

Biological functions

Genetic information storageCell cycleApoptosisReplicationTranscription
04

Disease associations

CancerInfectionGenetic disorderAutoimmune disease
05

Safety considerations

MyelosuppressionSecondary malignanciesTeratogenicityInfertilityNephrotoxicityGeneral cytotoxicity
06

Interacting drugs

Cisplatin

8 more in the full profile.

07

Biomarkers

gamma-H2AX (DNA damage marker)Microsatellite instability (MSI)Tumor mutational burden (TMB)DNA adduct levelsp53 status

Beyond the preview

Go deeper on DNA and other cellular components (DNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA and other cellular components (DNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call